Skip to content
Scroll To Top
- Niche clinical research organizations (CRO) are faster and more flexible than middle-sized to large-sized CROs. This agility can be valuable during the early stages of clinical trial development.
- Small CRO’s promptly adapt to changes in project scope and have shorter turnaround times to meet project milestones.
- Partnerships with small CRO’s and other third-party service providers can offer clients increased quality oversight and more accurate results with no conflict of interest.